The following industries match your search criteria:
Results are sorted by relevance.
Click on heading titles to sort results by different field.
New research from Datamonitor has suggested that the asthma/COPD market will enjoy a 35% increase and reach a value of over $18 billion by 2011. This growth will be largely driven by the success of drug delivery technology, rather than novel drug launches. GlaxoSmithKline should therefore be the main beneficiary of this market expansion although its rivals are looking to close the gap.
Edit my basket
© Datamonitor 2012. All rights reserved
Terms & Conditions